Key Statistics for 4506
|Current P/E Ratio (ttm)
Relative P/E vs.
|Earnings Per Share (JPY) (ttm)
|Est. EPS (JPY) (03/2014)
|Est. PEG Ratio
|Market Cap (M JPY)
|Shares Outstanding (M)
|30 Day Average Volume
|Dividend Indicated Gross Yield
|Cash Dividend (JPY)
|5 Year Dividend Growth
|Next Earnings Announcement
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for 4506
- Net Income (M/JPY)
Dainippon Sumitomo Pharma Co., Ltd. mainly manufactures and markets pharmaceuticals for human and veterinary use. The Company also produces and sells livestock feeds, food additives, and chemical products, and conducts clinical pathology tests for animals.
More Company Profile & Key Executives for 4506
|Masayo TadaPresident/CEO||Hiroshi NoguchiExecutive Vice President|
|Tetsuya OidaDirector||Makoto HaraSenior Managing Exec Officer|
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.